128 related articles for article (PubMed ID: 3324137)
1. Carbamazepine as an adjunct of antipsychotic therapy.
Dose M; Apelt S; Emrich HM
Psychiatry Res; 1987 Dec; 22(4):303-10. PubMed ID: 3324137
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment of schizophrenic psychoses with haloperidol and valproate.
Dose M; Hellweg R; Yassouridis A; Theison M; Emrich HM
Pharmacopsychiatry; 1998 Jul; 31(4):122-5. PubMed ID: 9754845
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsants as adjuncts for the neuroleptic treatment of schizophrenic psychoses: a clinical study with beclamide.
Raptis C; Garcia-Borreguero D; Weber MM; Dose M; Bremer D; Emrich HM
Acta Psychiatr Scand; 1990 Feb; 81(2):162-7. PubMed ID: 2183543
[TBL] [Abstract][Full Text] [Related]
4. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Klein E; Bental E; Lerer B; Belmaker RH
Arch Gen Psychiatry; 1984 Feb; 41(2):165-70. PubMed ID: 6365015
[TBL] [Abstract][Full Text] [Related]
5. Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
Möller HJ; Kissling W; Riehl T; Bäuml J; Binz U; Wendt G
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):127-36. PubMed ID: 2664882
[TBL] [Abstract][Full Text] [Related]
6. A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders.
Okuma T; Yamashita I; Takahashi R; Itoh H; Otsuki S; Watanabe S; Sarai K; Hazama H; Inanaga K
Acta Psychiatr Scand; 1989 Sep; 80(3):250-9. PubMed ID: 2573234
[TBL] [Abstract][Full Text] [Related]
7. Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophrenia.
Kahn EM; Schulz SC; Perel JM; Alexander JE
J Clin Psychopharmacol; 1990 Feb; 10(1):54-7. PubMed ID: 2106534
[TBL] [Abstract][Full Text] [Related]
8. [Carbamazepine: an effective adjuvant treatment in the schizophrenias].
Martín Muñoz JC; Moriñigo Domínguez AV; Mateo Martín I; Guajardo-Fajardo Ibarra I; Noval Lamos D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(4):245-50. PubMed ID: 2678932
[TBL] [Abstract][Full Text] [Related]
9. Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders.
König P; Chwatal K; Havelec L; Riedl F; Schubert H; Schultes H
Neuropsychobiology; 1996; 33(2):80-4. PubMed ID: 8927233
[TBL] [Abstract][Full Text] [Related]
10. Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial.
Wilson WH
Psychopharmacology (Berl); 1993; 111(3):359-66. PubMed ID: 7870975
[TBL] [Abstract][Full Text] [Related]
11. A controlled comparative study of chlorprothixene vs. haloperidol in chronic schizophrenia.
Fux M; Belmaker RH
Isr J Psychiatry Relat Sci; 1991; 28(1):37-40. PubMed ID: 1830565
[TBL] [Abstract][Full Text] [Related]
12. [Carbamazepine: an efficient adjuvant treatment in schizophrenia].
Martín Muñoz JC; Moriñigo Domínguez AV; Mateo Martín I; Guajardo-Fajardo Ibarra I; Noval Lamos D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(1):11-6. PubMed ID: 1502960
[TBL] [Abstract][Full Text] [Related]
13. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
14. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
15. [Carbamazepine in manic syndromes. A controlled double-blind study].
Gonçalves N; Stoll KD
Nervenarzt; 1985 Jan; 56(1):43-7. PubMed ID: 3883202
[No Abstract] [Full Text] [Related]
16. Exacerbation of psychosis after discontinuation of carbamazepine treatment.
Heh CW; Sramek J; Herrera J; Costa J
Am J Psychiatry; 1988 Jul; 145(7):878-9. PubMed ID: 2898213
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant treatment of schizophrenic illness with carbamazepine].
Hesslinger B; Klose P; Normann C; Langosch JM; Berger M; Walden J
Fortschr Neurol Psychiatr; 1998 Apr; 66(4):145-50. PubMed ID: 9587773
[TBL] [Abstract][Full Text] [Related]
18. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
19. Biperiden withdrawal in schizophrenic inpatients receiving long-term antipsychotic medication.
Wada Y; Koshino Y; Yamaguchi N
Clin Neuropharmacol; 1987 Aug; 10(4):370-5. PubMed ID: 2902920
[TBL] [Abstract][Full Text] [Related]
20. Lithium combined with haloperidol in schizophrenic patients.
Lerner Y; Mintzer Y; Schestatzky M
Br J Psychiatry; 1988 Sep; 153():359-62. PubMed ID: 3150693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
